Literature DB >> 30586071

The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.

Joachim Scholz1,2, Nanna B Finnerup3,4, Nadine Attal5,6, Qasim Aziz7, Ralf Baron8, Michael I Bennett9, Rafael Benoliel10, Milton Cohen11, Giorgio Cruccu12, Karen D Davis13,14, Stefan Evers15,16, Michael First17, Maria Adele Giamberardino18, Per Hansson19,20, Stein Kaasa21,22,23, Beatrice Korwisi24, Eva Kosek25, Patricia Lavand'homme26, Michael Nicholas27, Turo Nurmikko28, Serge Perrot29, Srinivasa N Raja30, Andrew S C Rice31, Michael C Rowbotham32, Stephan Schug33, David M Simpson34, Blair H Smith35, Peter Svensson36,37, Johan W S Vlaeyen38,39, Shuu-Jiun Wang40,41, Antonia Barke24, Winfried Rief24, Rolf-Detlef Treede42.   

Abstract

The upcoming 11th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD) of the World Health Organization (WHO) offers a unique opportunity to improve the representation of painful disorders. For this purpose, the International Association for the Study of Pain (IASP) has convened an interdisciplinary task force of pain specialists. Here, we present the case for a reclassification of nervous system lesions or diseases associated with persistent or recurrent pain for ≥3 months. The new classification lists the most common conditions of peripheral neuropathic pain: trigeminal neuralgia, peripheral nerve injury, painful polyneuropathy, postherpetic neuralgia, and painful radiculopathy. Conditions of central neuropathic pain include pain caused by spinal cord or brain injury, poststroke pain, and pain associated with multiple sclerosis. Diseases not explicitly mentioned in the classification are captured in residual categories of ICD-11. Conditions of chronic neuropathic pain are either insufficiently defined or missing in the current version of the ICD, despite their prevalence and clinical importance. We provide the short definitions of diagnostic entities for which we submitted more detailed content models to the WHO. Definitions and content models were established in collaboration with the Classification Committee of the IASP's Neuropathic Pain Special Interest Group (NeuPSIG). Up to 10% of the general population experience neuropathic pain. The majority of these patients do not receive satisfactory relief with existing treatments. A precise classification of chronic neuropathic pain in ICD-11 is necessary to document this public health need and the therapeutic challenges related to chronic neuropathic pain.

Entities:  

Mesh:

Year:  2019        PMID: 30586071      PMCID: PMC6310153          DOI: 10.1097/j.pain.0000000000001365

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  31 in total

1.  Creation of a clinical classification. International statistical classification of diseases and related health problems--10th revision, Australian modification (ICD-10-AM).

Authors:  K Innes; J Hooper; M Bramley; P DahDah
Journal:  Health Inf Manag       Date:  1997 Mar-May       Impact factor: 3.185

Review 2.  Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?

Authors:  Thuong Vo; Andrew S C Rice; Robert H Dworkin
Journal:  Pain       Date:  2009-04-10       Impact factor: 6.961

Review 3.  Neuropathic pain needs systematic classification.

Authors:  N B Finnerup; J Scholz; N Attal; R Baron; M Haanpää; P Hansson; S N Raja; A S C Rice; W Rief; M C Rowbotham; D M Simpson; R-D Treede
Journal:  Eur J Pain       Date:  2013-01-21       Impact factor: 3.931

Review 4.  Sodium channels in normal and pathological pain.

Authors:  Sulayman D Dib-Hajj; Theodore R Cummins; Joel A Black; Stephen G Waxman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 5.  The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain.

Authors:  Boya Nugraha; Christoph Gutenbrunner; Antonia Barke; Matthias Karst; Jörg Schiller; Peter Schäfer; Silke Falter; Beatrice Korwisi; Winfried Rief; Rolf-Detlef Treede
Journal:  Pain       Date:  2019-01       Impact factor: 6.961

6.  Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.

Authors: 
Journal:  Cephalalgia       Date:  2018-01       Impact factor: 6.292

Review 7.  Neuropathic pain in the general population: a systematic review of epidemiological studies.

Authors:  O van Hecke; Sophie K Austin; Rafi A Khan; B H Smith; N Torrance
Journal:  Pain       Date:  2013-11-26       Impact factor: 6.961

8.  Neuropathic pain: redefinition and a grading system for clinical and research purposes.

Authors:  R-D Treede; T S Jensen; J N Campbell; G Cruccu; J O Dostrovsky; J W Griffin; P Hansson; R Hughes; T Nurmikko; J Serra
Journal:  Neurology       Date:  2007-11-14       Impact factor: 9.910

Review 9.  Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Authors:  Robert R Edwards; Robert H Dworkin; Dennis C Turk; Martin S Angst; Raymond Dionne; Roy Freeman; Per Hansson; Simon Haroutounian; Lars Arendt-Nielsen; Nadine Attal; Ralf Baron; Joanna Brell; Shay Bujanover; Laurie B Burke; Daniel Carr; Amy S Chappell; Penney Cowan; Mila Etropolski; Roger B Fillingim; Jennifer S Gewandter; Nathaniel P Katz; Ernest A Kopecky; John D Markman; George Nomikos; Linda Porter; Bob A Rappaport; Andrew S C Rice; Joseph M Scavone; Joachim Scholz; Lee S Simon; Shannon M Smith; Jeffrey Tobias; Tina Tockarshewsky; Christine Veasley; Mark Versavel; Ajay D Wasan; Warren Wen; David Yarnitsky
Journal:  Pain       Date:  2016-09       Impact factor: 7.926

Review 10.  Neuropathic pain: an updated grading system for research and clinical practice.

Authors:  Nanna B Finnerup; Simon Haroutounian; Peter Kamerman; Ralf Baron; David L H Bennett; Didier Bouhassira; Giorgio Cruccu; Roy Freeman; Per Hansson; Turo Nurmikko; Srinivasa N Raja; Andrew S C Rice; Jordi Serra; Blair H Smith; Rolf-Detlef Treede; Troels S Jensen
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

View more
  133 in total

1.  Chronic nanocurcumin treatment ameliorates pain-related behavior, improves spatial memory, and reduces hippocampal levels of IL-1β and TNFα in the chronic constriction injury model of neuropathic pain.

Authors:  Sepideh Saffarpour; Atousa Janzadeh; Behnaz Rahimi; Fatemeh Ramezani; Farinaz Nasirinezhad
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

2.  Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results.

Authors:  Oyebimpe O Adesina; James G Gurney; Guolian Kang; Martha Villavicencio; Jason R Hodges; Wassim Chemaitilly; Sue C Kaste; Babette S Zemel; Jane S Hankins
Journal:  Blood Adv       Date:  2019-05-14

Review 3.  Neuropathic pain in sickle cell disease: measurement and management.

Authors:  Alexander Glaros; Amanda M Brandow
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 4.  Persistent dentoalveolar pain disorder: A putative intraoral chronic overlapping pain condition.

Authors:  Alberto Herrero Babiloni; Donald R Nixdorf; Estephan J Moana-Filho
Journal:  Oral Dis       Date:  2019-12-17       Impact factor: 3.511

5.  Neuromodulation in the treatment of postoperative epidural fibrosis: comparison of the extent of epidural fibrosis and the effect of stimulation.

Authors:  V Masopust; J Holubová; P Skalický; R Rokyta; J Fricová; J Lacman; D Netuka; J Patríková; K Janoušková
Journal:  Physiol Res       Date:  2021-05-12       Impact factor: 1.881

Review 6.  Modulation of Pathological Pain by Epidermal Growth Factor Receptor.

Authors:  Jazlyn P Borges; Katrina Mekhail; Gregory D Fairn; Costin N Antonescu; Benjamin E Steinberg
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

7.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

Review 8.  Stem Cell Therapy for Modulating Neuroinflammation in Neuropathic Pain.

Authors:  Hari Prasad Joshi; Hyun-Jung Jo; Yong-Ho Kim; Seong-Bae An; Chul-Kyu Park; Inbo Han
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

9.  Isolated Lumbar Extension Resistance Exercise in Limited Range of Motion for Patients with Lumbar Radiculopathy and Disk Herniation-Clinical Outcome and Influencing Factors.

Authors:  Witold Golonka; Christoph Raschka; Vahid M Harandi; Bruno Domokos; Håkan Alfredson; Florian Maria Alfen; Christoph Spang
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

Review 10.  Needling Interventions for Sciatica: Choosing Methods Based on Neuropathic Pain Mechanisms-A Scoping Review.

Authors:  Thomas Perreault; César Fernández-de-Las-Peñas; Mike Cummings; Barry C Gendron
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.